Results 201 to 210 of about 715,660 (339)

Disease Modifying Monoclonal Antibodies and Symptomatic Pharmacological Treatment for Alzheimer's Disease. [PDF]

Biomedicines
Qi X, Nizamutdinov D, Yi SS, Wu E, Huang JH.   +4 more
europepmc   +1 more source

Antigenic analysis of Serratia marcescens fimbriae with monoclonal antibodies [PDF]

, 1987
Seiya Jingushi, Masao Mitsuyama, Toshimitsu Moriya, Kazunobu Amako   +3 more
openalex   +1 more source

YC‐4‐3, a Novel Glycogen Synthase Kinase 3β Inhibitor, Alleviates the Endoplasmic Reticulum Stress of Macrophages in Primary Immune Thrombocytopenia

Advanced Science, EarlyView.
A patented GSK‐3β inhibitor (GSK‐3βi), new benzothiazepinone compounds (BTZs), YC‐4‐3, can modulate the inflammatory status of macrophages in primary immune thrombocytopenia (ITP), and improve the thrombocytopenia in murine ITP models by directly interacting with endoplasmic reticulum (ER) stress response.
Pengcheng Xu, Lili Ji, Yanxia Zhan, Yang Ou, Xia Shao, Xibing Zhuang, Fanli Hua, Feng Li, Hao Chen, Yong Chu, Yunfeng Cheng   +10 more
wiley   +1 more source

Preparation and application evaluation of monoclonal antibodies against Monkeypox virus A29 protein. [PDF]

Front Microbiol
Xiangjun A, Xinlan Z, Ye X, Chufan T, Chen D, Nami L, Junxi L, Yilan Q, Defu H, Qinglin W, Rushi L.   +10 more
europepmc   +1 more source

Efficient generation in vitro, from human peripheral blood cells, of monoclonal Epstein-Barr virus transformants producing specific antibody to a variety of antigens without prior deliberate immunization.

, 1983
Larry Winger, Caroline M. Winger, Padma Shastry, Amanda J. Russell, Michael Longenecker   +4 more
openalex   +1 more source

A rapid method for the selective identification ofAutographa californicanuclear polyhedrosis virus using a monoclonal antibody [PDF]

, 1982
Werner L. Naser, H.G. Miltenburger
openalex   +1 more source

The Super Enhancer‐Driven Long Noncoding RNA PRKCQ‐AS1 Promotes Neuroblastoma Tumorigenesis by Interacting With MSI2 Protein and Is Targetable by Small Molecule Compounds

Advanced Science, EarlyView.
PRKCQ‐AS1 is overexpressed due to transcriptional super‐enhancers. PRKCQ‐AS1 RNA forms a complex with MSI2 protein to induce BMX mRNA stabilization and overexpression, ERK protein phosphorylation and neuroblastoma cell proliferation. Compound NSC617570 blocks PRKCQ‐AS1 binding to MSI2, leading to BMX mRNA disassociation from MSI2 protein, BMX reduction,
Sujanna Mondal, Pei Y. Liu, Janith Seneviratne, Antoine De Weck, Pooja Venkat, Chelsea Mayoh, Jing Wu, Jesper Maag, Jingwei Chen, Matthew Wong, Nenad Bartonicek, Poh Khoo, Lei Jin, Louise E. Ludlow, David S. Ziegler, Toby Trahair, Pieter Mestdagh, Belamy B. Cheung, Jinyan Li, Marcel E. Dinger, Ian Street, Xu D. Zhang, Glenn M. Marshall, Tao Liu   +23 more
wiley   +1 more source

Rat as a Predictive Model for Human Clearance and Bioavailability of Monoclonal Antibodies. [PDF]

Antibodies (Basel)
Robarge JD, Budge KM, Her L, Patterson AM, Brown-Augsburger P.   +4 more
europepmc   +1 more source

Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery

Advanced Science, EarlyView.
The Y‐Hydroporator is a microfluidic gene delivery platform designed for allogeneic NK cell‐based immunotherapies. It achieves highly efficient gene delivery while preserving high cell viability and functionality. By producing engineered NK cells with enhanced cytotoxicity, the platform addresses critical limitations of autologous cell therapy ...
Hyelee Kim, Mujin Lee, Bohwa Han, Jinho Kim, Duck Cho, Junsang Doh, Aram J. Chung   +6 more
wiley   +1 more source

Update on development of monoclonal antibodies for use in clinical flow cytometry and research in dogs. [PDF]

J Vet Diagn Invest
de Souza C, Fidel J, Davis WC.
europepmc   +1 more source